Your session is about to expire
← Back to Search
Rehab Program for Spinal Stenosis
N/A
Recruiting
Research Sponsored by Université du Québec à Trois-Rivières
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 2, week 4, week 6, week 12
Awards & highlights
Study Summary
This trial will test if a 6-week rehab program combining education and exercises can improve walking capacity in lower back pain patients.
Who is the study for?
This trial is for people over 50 with lumbar spinal stenosis (LSS) causing nerve compression, who can speak French and commit to three sessions a week. They should be able to walk 20 meters but not continuously for 30 minutes. Excluded are those with congenital LSS, significant hip/knee arthritis, neurological diseases like Parkinson's, uncontrolled diabetes, heart failure, vascular claudication or recent back surgery.Check my eligibility
What is being tested?
The study tests if a specific 6-week program of education plus exercises improves walking in LSS patients compared to education alone. Participants will be checked at the start, after weeks two and four, and post-intervention on their walking ability, pain levels, disability due to LSS, self-efficacy and mental health.See study design
What are the potential side effects?
Potential side effects from the exercise program may include muscle soreness or strain. The educational component is unlikely to have side effects but could potentially cause some anxiety or stress related to learning about one's condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, week 2, week 4, week 6, week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 2, week 4, week 6, week 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline in walking capacity
Secondary outcome measures
Change from baseline in anxiety and depression
Change from baseline in biomechanical parameters of gait
Change from baseline in leg and back pain intensity
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Intervention GroupExperimental Treatment1 Intervention
Intervention group will received education and a specific rehabilitation program (exercises).
Group II: Control GroupExperimental Treatment1 Intervention
Control group will received education alone.
Find a Location
Who is running the clinical trial?
Université du Québec à Trois-RivièresLead Sponsor
43 Previous Clinical Trials
4,367 Total Patients Enrolled
5 Trials studying Spinal Stenosis
313 Patients Enrolled for Spinal Stenosis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My diabetes is not under control.I have heart failure.I can speak and understand French.I experience leg pain from walking due to poor blood flow.I can attend 3 sessions a week.I have difficulty thinking or making decisions.I have painful arthritis in my hip or knee that makes it hard to walk.I am 50 years old or older.My symptoms have been present for at least 3 months.I have a neurological condition like Parkinson's that affects my ability to walk.I have been diagnosed with spinal stenosis and/or slipped vertebrae through exams and imaging.I have had back or leg surgery in the last 3 months.I have nerve compression due to lumbar spinal stenosis.I can walk 20 meters without help but can't walk for 30 minutes straight.
Research Study Groups:
This trial has the following groups:- Group 1: Control Group
- Group 2: Intervention Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this medical experiment recruiting participants?
"The data available on clinicaltrials.gov suggests that this trial is actively looking for new participants, with the original posting date being January 26th 2023 and last updated as of May 8th 2023."
Answered by AI
What is the cap on enrollment in this trial?
"Affirmative. Clinicaltrials.gov evidences that this clinical investigation, which was initially published on January 26th 2023, is currently recruiting participants. A total of 66 patients must be enrolled from 1 trial site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger